Biosimilar Etanercept Use in Rheumatoid Arthritis: The Rhumadata Registry Experience

被引：0
|
作者：
Moura, Cristiano [1 ]
Bernatsky, Sasha [2 ]
Coupal, Louis [3 ]
Bessette, Louis [4 ]
Choquette, Denis [3 ]
机构：
[1] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada
[2] McGill Univ, Ctr Hlth, Montreal, PQ, Canada
[3] Inst Rhumatol Montreal, Montreal, PQ, Canada
[4] Laval Univ, Quebec City, PQ, Canada
来源：
JOURNAL OF RHEUMATOLOGY | 2020年 / 47卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
176
引用
收藏
页码：1107 / 1107
页数：1
相关论文
共 50 条
  • [31] OUTCOMES OF ETANERCEPT THERAPY IN ELDERLY RHEUMATOID ARTHRITIS PATIENTS: AN INVESTIGATION OF THE AKITA ORTHOPEDIC GROUP ON RHEUMATOID ARTHRITIS REGISTRY
    Aonuma, H.
    Kashiwagura, T.
    Urayama, M.
    Kobayashi, M.
    Aizawa, T.
    Sugimura, Y.
    Miyakoshi, N.
    Shimada, Y.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1182 - 1182
  • [32] Etanercept originator versus etanercept biosimilar for the treatment of rheumatoid arthritis as a first biologic: results from the BSRBR-RA
    Kearsley-Fleet, Lianne
    Rokad, Aasiyah
    Tsoi, Man-Fung
    Zhao, Sizheng Steven
    Lunt, Mark
    Watson, Kath D.
    Hyrich, Kimme L.
    [J]. RHEUMATOLOGY, 2023, 62 (12): : 3849 - 3857
  • [33] Etanercept in severe active rheumatoid arthritis: first Australian experience
    Perera, L. C.
    Tymms, K. E.
    Wilson, B. J.
    Shadbolt, B.
    Brook, A. S.
    Raj, A. K. Dorai
    Khoo, K. B. K.
    [J]. INTERNAL MEDICINE JOURNAL, 2006, 36 (10) : 625 - 631
  • [34] Etanercept:: long-term clinical experience in rheumatoid arthritis and other arthritis
    Cobo-Ibanez, T.
    Martin-Mola, E.
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (09) : 1373 - 1397
  • [35] Efficacy and Safety of Biosimilar and Originator Etanercept in Rheumatoid Arthritis Patients: Real-Life Data
    Atzeni, Fabiola
    Gerratana, Elisabetta
    Bongiovanni, Sara
    Talotta, Rossella
    Miceli, Gianfranco
    Salaffi, Fausto
    Sarzi-Puttini, Piercarlo
    [J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2021, 23 (06): : 344 - 349
  • [36] Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis
    Rho, Young Hee
    Rychlewska-Hanczewska, Anna
    Sliwowska, Beata
    Kim, Tae Hyung
    [J]. ADVANCES IN THERAPY, 2019, 36 (09) : 2287 - 2295
  • [37] Comparative effectiveness of etanercept originator and biosimilar for treating rheumatoid arthritis: implications for cost-savings
    Deakin, Claire T.
    Littlejohn, Geoffrey O.
    Griffiths, Hedley
    Ciciriello, Sabina
    O'Sullivan, Catherine
    Smith, Tegan
    Youssef, Peter
    Bird, Paul
    [J]. INTERNAL MEDICINE JOURNAL, 2024, 54 (05) : 795 - 801
  • [38] CLINICAL OUTCOMES OF A MULTI-DISCIPLINARY SWITCHING PROGRAMME TO BIOSIMILAR ETANERCEPT FOR PATIENTS WITH RHEUMATOID ARTHRITIS
    Shah, Kavina
    Flora, Kalveer
    Penn, Henry
    [J]. RHEUMATOLOGY, 2018, 57
  • [39] NO DIFFERENCE IN EFFECTIVENESS WITH EITHER ETANERCEPT ORIGINATOR OR BIOSIMILAR AS FIRST LINE BIOLOGIC TREATMENT FOR RHEUMATOID ARTHRITIS
    De Cock, D.
    Davies, R.
    Kearsley-Fleet, L.
    Watson, K.
    Hyrich, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1377 - 1378
  • [40] Usability of Prefilled Syringe and Autoinjector for SB4 (An Etanercept Biosimilar) in Patients with Rheumatoid Arthritis
    Young Hee Rho
    Anna Rychlewska-Hańczewska
    Beata Śliwowska
    Tae Hyung Kim
    [J]. Advances in Therapy, 2019, 36 : 2287 - 2295
12345